View Future GrowthDenka 過去の業績過去 基準チェック /26Denkaの収益は年間平均-44.4%の割合で減少していますが、 Chemicals業界の収益は年間 増加しています。収益は年間5.4% 1.1%割合で 増加しています。 Denkaの自己資本利益率は3.3%であり、純利益率は4.1%です。主要情報-44.43%収益成長率-44.42%EPS成長率Chemicals 業界の成長6.58%収益成長率1.08%株主資本利益率3.32%ネット・マージン4.08%次回の業績アップデート07 Aug 2026最近の業績更新分析記事 • May 21We Like Denka's (TSE:4061) Earnings For More Than Just Statutory ProfitThe market seemed underwhelmed by the solid earnings posted by Denka Company Limited ( TSE:4061 ) recently. Our...Reported Earnings • May 14Full year 2026 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2026 results: EPS: JP¥182 (up from JP¥143 loss in FY 2025). Revenue: JP¥384.2b (down 4.0% from FY 2025). Net income: JP¥15.7b (up JP¥28.0b from FY 2025). Profit margin: 4.1% (up from net loss in FY 2025). The move to profitability was driven by lower expenses. Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) exceeded analyst estimates by 6.5%. Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.お知らせ • Apr 22+ 3 more updatesDenka Company Limited to Report Q2, 2027 Results on Nov 09, 2026Denka Company Limited announced that they will report Q2, 2027 results on Nov 09, 2026Reported Earnings • Feb 07Third quarter 2026 earnings: EPS and revenues miss analyst expectationsThird quarter 2026 results: EPS: JP¥18.94 (up from JP¥9.23 loss in 3Q 2025). Revenue: JP¥94.1b (down 8.3% from 3Q 2025). Net income: JP¥1.63b (up JP¥2.43b from 3Q 2025). Profit margin: 1.7% (up from net loss in 3Q 2025). Revenue missed analyst estimates by 8.1%. Earnings per share (EPS) also missed analyst estimates by 72%. Revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance.お知らせ • Dec 24Denka Company Limited to Report Q3, 2026 Results on Feb 06, 2026Denka Company Limited announced that they will report Q3, 2026 results on Feb 06, 2026Reported Earnings • Nov 11Second quarter 2026 earnings: EPS misses analyst expectationsSecond quarter 2026 results: JP¥12.75 loss per share (down from JP¥13.02 profit in 2Q 2025). Revenue: JP¥102.6b (down 1.2% from 2Q 2025). Net loss: JP¥1.10b (down 198% from profit in 2Q 2025). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates. Revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance.すべての更新を表示Recent updatesValuation Update With 7 Day Price Move • May 29Investor sentiment improves as stock rises 16%After last week's 16% share price gain to JP¥4,480, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 15x in the Chemicals industry in Japan. Total returns to shareholders of 97% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at JP¥6,464 per share.分析記事 • May 21We Like Denka's (TSE:4061) Earnings For More Than Just Statutory ProfitThe market seemed underwhelmed by the solid earnings posted by Denka Company Limited ( TSE:4061 ) recently. Our...Reported Earnings • May 14Full year 2026 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2026 results: EPS: JP¥182 (up from JP¥143 loss in FY 2025). Revenue: JP¥384.2b (down 4.0% from FY 2025). Net income: JP¥15.7b (up JP¥28.0b from FY 2025). Profit margin: 4.1% (up from net loss in FY 2025). The move to profitability was driven by lower expenses. Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) exceeded analyst estimates by 6.5%. Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.お知らせ • May 13Denka Company Limited, Annual General Meeting, Jun 19, 2026Denka Company Limited, Annual General Meeting, Jun 19, 2026.お知らせ • Apr 22+ 3 more updatesDenka Company Limited to Report Q2, 2027 Results on Nov 09, 2026Denka Company Limited announced that they will report Q2, 2027 results on Nov 09, 2026お知らせ • Mar 26Denka Company Limited (TSE:4061) completed the acquisition of 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders.Denka Company Limited (TSE:4061) proposed to acquire 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders for ¥7.9 billion on February 6, 2026. A cash consideration of ¥7.89 billion valued at ¥2285 per share will be paid by Denka Company Limited. As part of consideration, ¥7.89 billion is paid towards common equity of KAINOS Laboratories, Inc. Denka Company Limited intends to launch a Squeeze-Out Procedures, if it acquires the minimum tender shares (1,990,000 shares) and fails to acquire all of the KAINOS Laboratories, Inc's Shares (excluding the Shares Agreed Not to Be Tendered and treasury shares). The transaction is subject to minimum tender. The expected completion of the transaction is March 25, 2026. Sumitomo Mitsui Banking Corporation acted as financial advisor for Denka Company Limited. AGS Consulting Co., Ltd. acted as financial advisor for KAINOS Laboratories, Inc. Nagashima Ohno & Tsunematsu acted as legal advisor for KAINOS Laboratories, Inc. TMI Associates acted as legal advisor for KAINOS Laboratories, Inc. Mizuho Securities Co., Ltd. acted as financial advisor for KAINOS Laboratories, Inc. Denka Company Limited (TSE:4061) completed the acquisition of 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders on March 25, 2026. Upon closing of the offer period, 3,223,919 shares were tendered. Since it is more than the minimum number of shares to be purchased (1,990,000 shares), Denka Company Limited will purchase all of the Tendered Share Certificates and intends to implement a series of procedures for the purpose of making the Tender Offeror the sole shareholder of KAINOS Laboratories, Inc. As of today, the KAINOS Laboratories, Inc's Shares are listed on the Standard Market of the Tokyo Stock Exchange. If the procedures are implemented, the KAINOS Laboratories, Inc's Shares will be delisted pursuant to the prescribed procedures, in accordance with the criteria for delisting of Tokyo Stock Exchange. KAINOS Laboratories, Inc's Shares, after being delisted, will no longer be traded on the Standard Market of the Tokyo Stock Exchange.Price Target Changed • Mar 24Price target increased by 7.5% to JP¥3,866Up from JP¥3,597, the current price target is an average from 7 analysts. New target price is 17% above last closing price of JP¥3,294. Stock is up 47% over the past year. The company is forecast to post earnings per share of JP¥171 next year compared to a net loss per share of JP¥143 last year.Upcoming Dividend • Mar 23Upcoming dividend of JP¥50.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 23 June 2026. The company is not currently making a profit and is not cash flow positive. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.3%).New Risk • Mar 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (13% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risk Share price has been volatile over the past 3 months (6.2% average weekly change).お知らせ • Mar 10Denka Company Limited (TSE:4061) enter into a share transfer agreement to acquire an additional 15% stake in Toyo Styrene Co. Ltd from Daicel Corporation (TSE:4202).Denka Company Limited (TSE:4061) enter into a share transfer agreement to acquire an additional 15% stake in Toyo Styrene Co. Ltd from Daicel Corporation (TSE:4202) on March 9, 2026. Upon completion, Denka Company Limited will own 65% stake in Toyo Styrene Co. Ltd. As a result of this transaction, Toyo Styrene is expected to become a consolidated subsidiary of the Company that qualifies as a specified subsidiary. Daicel will cease to be a co-investor in Toyo Styrene, and Toyo Styrene’s Hirohata Plant will be shut down. For a certain period, however, Toyo Styrene will continue to outsource production to Daicel and maintain product sales. For the period ending March 31, 2025, Toyo Styrene Co. Ltd reported total revenue of ¥48.39 billion, EBIT of ¥1.22 billion and net income of ¥788 million. As of March 31, 2025, Toyo Styrene Co. Ltd reported total assets of ¥27.69 billion and total common equity of ¥11.73 billion. The completion of this share transfer is subject to the completion of the necessary approvals, permissions, or clearances from the relevant authorities in accordance with the Anti-Monopoly Act and other applicable laws and regulations. The expected completion of the transaction is March 31, 2026.Price Target Changed • Mar 02Price target increased by 8.2% to JP¥3,469Up from JP¥3,206, the current price target is an average from 7 analysts. New target price is approximately in line with last closing price of JP¥3,496. Stock is up 69% over the past year. The company is forecast to post earnings per share of JP¥179 next year compared to a net loss per share of JP¥143 last year.分析記事 • Feb 09Denka (TSE:4061) Has Announced A Dividend Of ¥50.00The board of Denka Company Limited ( TSE:4061 ) has announced that it will pay a dividend on the 23rd of June, with...お知らせ • Feb 09Denka Company Limited (TSE:4061) proposed to acquire 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders for ¥7.9 billion.Denka Company Limited (TSE:4061) proposed to acquire 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders for ¥7.9 billion on February 6, 2026. A cash consideration of ¥7.89 billion valued at ¥2285 per share will be paid by Denka Company Limited. As part of consideration, ¥7.89 billion is paid towards common equity of KAINOS Laboratories, Inc. The transaction is subject to minimum tender. The expected completion of the transaction is March 25, 2026. Sumitomo Mitsui Banking Corporation acted as financial advisor for Denka Company Limited. AGS Consulting Co., Ltd. acted as financial advisor for KAINOS Laboratories, Inc. Nagashima Ohno & Tsunematsu acted as legal advisor for KAINOS Laboratories, Inc. TMI Associates acted as legal advisor for KAINOS Laboratories, Inc. Mizuho Securities Co., Ltd. acted as financial advisor for KAINOS Laboratories, Inc.Reported Earnings • Feb 07Third quarter 2026 earnings: EPS and revenues miss analyst expectationsThird quarter 2026 results: EPS: JP¥18.94 (up from JP¥9.23 loss in 3Q 2025). Revenue: JP¥94.1b (down 8.3% from 3Q 2025). Net income: JP¥1.63b (up JP¥2.43b from 3Q 2025). Profit margin: 1.7% (up from net loss in 3Q 2025). Revenue missed analyst estimates by 8.1%. Earnings per share (EPS) also missed analyst estimates by 72%. Revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance.分析記事 • Feb 05Denka Company Limited's (TSE:4061) Price Is Out Of Tune With RevenuesIt's not a stretch to say that Denka Company Limited's ( TSE:4061 ) price-to-sales (or "P/S") ratio of 0.7x seems quite...分析記事 • Jan 14Denka (TSE:4061) Has A Somewhat Strained Balance SheetThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Price Target Changed • Jan 06Price target increased by 10% to JP¥3,167Up from JP¥2,867, the current price target is an average from 7 analysts. New target price is 10% above last closing price of JP¥2,876. Stock is up 28% over the past year. The company is forecast to post earnings per share of JP¥178 next year compared to a net loss per share of JP¥143 last year.分析記事 • Dec 24Denka (TSE:4061) Will Pay A Dividend Of ¥50.00The board of Denka Company Limited ( TSE:4061 ) has announced that it will pay a dividend of ¥50.00 per share on the...お知らせ • Dec 24Denka Company Limited to Report Q3, 2026 Results on Feb 06, 2026Denka Company Limited announced that they will report Q3, 2026 results on Feb 06, 2026分析記事 • Dec 03Denka (TSE:4061) Will Pay A Dividend Of ¥50.00The board of Denka Company Limited ( TSE:4061 ) has announced that it will pay a dividend of ¥50.00 per share on the...Declared Dividend • Dec 03First half dividend of JP¥50.00 announcedDividend of JP¥50.00 is the same as last year. Ex-date: 30th March 2026 Payment date: 23rd June 2026 Dividend yield will be 3.8%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 7.2% per year over the past 10 years. However, payments have been volatile during that time.Price Target Changed • Nov 26Price target increased by 13% to JP¥2,696Up from JP¥2,380, the current price target is an average from 7 analysts. New target price is 6.0% above last closing price of JP¥2,543. Stock is up 19% over the past year. The company is forecast to post earnings per share of JP¥181 next year compared to a net loss per share of JP¥143 last year.Price Target Changed • Nov 14Price target increased by 8.5% to JP¥2,338Up from JP¥2,155, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of JP¥2,448. Stock is up 20% over the past year. The company is forecast to post earnings per share of JP¥172 next year compared to a net loss per share of JP¥143 last year.Reported Earnings • Nov 11Second quarter 2026 earnings: EPS misses analyst expectationsSecond quarter 2026 results: JP¥12.75 loss per share (down from JP¥13.02 profit in 2Q 2025). Revenue: JP¥102.6b (down 1.2% from 2Q 2025). Net loss: JP¥1.10b (down 198% from profit in 2Q 2025). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates. Revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance.分析記事 • Oct 14Denka Company Limited (TSE:4061) Not Flying Under The RadarIt's not a stretch to say that Denka Company Limited's ( TSE:4061 ) price-to-sales (or "P/S") ratio of 0.5x right now...Upcoming Dividend • Sep 22Upcoming dividend of JP¥50.00 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 03 December 2025. The company is not currently making a profit and is not cash flow positive. Trailing yield: 4.2%. Within top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.6%).分析記事 • Sep 22Denka (TSE:4061) Is Due To Pay A Dividend Of ¥50.00The board of Denka Company Limited ( TSE:4061 ) has announced that it will pay a dividend of ¥50.00 per share on the...お知らせ • Sep 22Denka Company Limited(TSE:4061) dropped from FTSE All-World Index (USD)Denka Company Limited(TSE:4061) dropped from FTSE All-World Index (USD)分析記事 • Sep 03Denka (TSE:4061) Will Pay A Dividend Of ¥50.00The board of Denka Company Limited ( TSE:4061 ) has announced that it will pay a dividend on the 3rd of December, with...お知らせ • Sep 03Denka Company Limited to Report Q2, 2026 Results on Nov 10, 2025Denka Company Limited announced that they will report Q2, 2026 results on Nov 10, 2025Reported Earnings • Aug 08First quarter 2026 earnings: EPS exceeds analyst expectations while revenues lag behindFirst quarter 2026 results: EPS: JP¥58.03 (up from JP¥26.11 in 1Q 2025). Revenue: JP¥94.1b (down 1.2% from 1Q 2025). Net income: JP¥5.00b (up 122% from 1Q 2025). Profit margin: 5.3% (up from 2.4% in 1Q 2025). Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) exceeded analyst estimates significantly. Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 54 percentage points per year, which is a significant difference in performance.Board Change • Jul 25Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Outside Director Rumiko Nakata was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.分析記事 • Jul 24Denka (TSE:4061) Has Affirmed Its Dividend Of ¥50.00Denka Company Limited ( TSE:4061 ) will pay a dividend of ¥50.00 on the 3rd of December. The dividend yield will be...分析記事 • Jul 10Denka (TSE:4061) Has Announced A Dividend Of ¥50.00Denka Company Limited ( TSE:4061 ) will pay a dividend of ¥50.00 on the 3rd of December. This makes the dividend yield...Declared Dividend • Jul 09Final dividend of JP¥50.00 announcedDividend of JP¥50.00 is the same as last year. Ex-date: 29th September 2025 Payment date: 3rd December 2025 Dividend yield will be 4.8%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is covered by earnings (71% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 7.2% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 373% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Jul 02Denka Company Limited to Report Q1, 2026 Results on Aug 07, 2025Denka Company Limited announced that they will report Q1, 2026 results on Aug 07, 2025Reported Earnings • Jun 24Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: JP¥143 loss per share (down from JP¥139 profit in FY 2024). Revenue: JP¥400.3b (up 2.8% from FY 2024). Net loss: JP¥12.3b (down 203% from profit in FY 2024). Revenue missed analyst estimates by 2.0%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 1.7% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.分析記事 • Jun 16Is Denka (TSE:4061) A Risky Investment?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...New Risk • May 15New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. The company is paying a dividend despite being loss-making. The company is paying a dividend despite having no free cash flows. Dividend yield: 5.0% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (8.6% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows.Reported Earnings • May 14Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: JP¥143 loss per share (down from JP¥139 profit in FY 2024). Revenue: JP¥400.3b (up 2.8% from FY 2024). Net loss: JP¥12.3b (down 203% from profit in FY 2024). Revenue missed analyst estimates by 2.0%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 2.1% p.a. on average during the next 2 years, compared to a 4.6% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings.分析記事 • May 13The Returns On Capital At Denka (TSE:4061) Don't Inspire ConfidenceThere are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...お知らせ • May 13+ 3 more updatesDenka Company Limited, Annual General Meeting, Jun 20, 2025Denka Company Limited, Annual General Meeting, Jun 20, 2025.Major Estimate Revision • Apr 29Consensus EPS estimates fall by 34%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from JP¥34.22 to JP¥22.53 per share. Revenue forecast steady at JP¥408.4b. Net income forecast to grow 6.5% next year vs 7.2% growth forecast for Chemicals industry in Japan. Consensus price target broadly unchanged at JP¥2,463. Share price rose 3.1% to JP¥1,955 over the past week.Valuation Update With 7 Day Price Move • Apr 07Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to JP¥1,784, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 10x in the Chemicals industry in Japan. Total loss to shareholders of 39% over the past three years.Upcoming Dividend • Mar 21Upcoming dividend of JP¥50.00 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 23 June 2025. Payout ratio is a comfortable 71% but the company is not cash flow positive. Trailing yield: 4.0%. Within top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (2.6%).Major Estimate Revision • Mar 15Consensus EPS estimates increase by 29%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from JP¥40.53 to JP¥52.30. Revenue forecast steady at JP¥407.9b. Net income forecast to grow 13% next year vs 8.3% growth forecast for Chemicals industry in Japan. Consensus price target broadly unchanged at JP¥2,491. Share price rose 2.4% to JP¥2,200 over the past week.Major Estimate Revision • Mar 13Consensus EPS estimates fall by 27%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from JP¥40.53 to JP¥29.69 per share. Revenue forecast steady at JP¥409.3b. Net income forecast to grow 11% next year vs 8.3% growth forecast for Chemicals industry in Japan. Consensus price target broadly unchanged at JP¥2,491. Share price rose 4.4% to JP¥2,215 over the past week.お知らせ • Mar 12Oriental Shiraishi Corporation (TSE:1786) signed a share transfer agreement to acquire 51% stake in Denka Renotec Co., Ltd. from Denka Company Limited (TSE:4061).Oriental Shiraishi Corporation (TSE:1786) signed a share transfer agreement to acquire 51% stake in Denka Renotec Co., Ltd. from Denka Company Limited (TSE:4061) on March 12, 2025. Even after the transfer of shares, Denka Renotec will remain an equity-method affiliate of Denka Company Limited.Reported Earnings • Feb 08Third quarter 2025 earnings: EPS and revenues miss analyst expectationsThird quarter 2025 results: JP¥9.23 loss per share (improved from JP¥34.55 loss in 3Q 2024). Revenue: JP¥102.5b (up 1.1% from 3Q 2024). Net loss: JP¥795.0m (loss narrowed 73% from 3Q 2024). Revenue missed analyst estimates by 3.9%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 1.7% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.Major Estimate Revision • Jan 29Consensus EPS estimates fall by 13%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from JP¥42.94 to JP¥37.52 per share. Revenue forecast steady at JP¥409.6b. Net income forecast to grow 4.8% next year vs 13% growth forecast for Chemicals industry in Japan. Consensus price target broadly unchanged at JP¥2,477. Share price rose 5.7% to JP¥2,244 over the past week.分析記事 • Jan 27Denka (TSE:4061) Use Of Debt Could Be Considered RiskyThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Major Estimate Revision • Jan 17Consensus EPS estimates fall from profit to JP¥1.16 lossThe consensus outlook for fiscal year 2025 has been updated. Expected to report loss instead of -JP¥1.16 instead of JP¥18.90 per share profit previously forecast. Revenue forecast unchanged at JP¥409.3b Chemicals industry in Japan expected to see average net income growth of 13% next year. Consensus price target broadly unchanged at JP¥2,493. Share price fell 3.2% to JP¥2,104 over the past week.Major Estimate Revision • Jan 11Consensus EPS estimates fall by 50%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from JP¥18.90 to JP¥9.48 per share. Revenue forecast steady at JP¥409.3b. Net income forecast to shrink 11% next year vs 13% growth forecast for Chemicals industry in Japan . Consensus price target of JP¥2,507 unchanged from last update. Share price fell 2.6% to JP¥2,173 over the past week.分析記事 • Dec 30Denka (TSE:4061) Could Be Struggling To Allocate CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...Major Estimate Revision • Dec 27Consensus EPS estimates increase from loss to JP¥18.90 profitThe consensus outlook for fiscal year 2025 has been updated. 2025 forecast for profit of -JP¥6.63 instead of a loss of JP¥18.90 per share previously. Revenue forecast unchanged at JP¥409.1b. Chemicals industry in Japan expected to see average net income growth of 13% next year. Consensus price target broadly unchanged at JP¥2,507. Share price rose 5.4% to JP¥2,218 over the past week.Major Estimate Revision • Dec 13Consensus EPS estimates fall from profit to JP¥6.63 lossThe consensus outlook for fiscal year 2025 has been updated. Expected to report loss instead of -JP¥6.63 instead of JP¥21.46 per share profit previously forecast. Revenue forecast unchanged at JP¥409.1b Chemicals industry in Japan expected to see average net income growth of 13% next year. Consensus price target broadly unchanged at JP¥2,534. Share price was steady at JP¥2,167 over the past week.お知らせ • Dec 03Denka Company Limited to Report Q3, 2025 Results on Feb 07, 2025Denka Company Limited announced that they will report Q3, 2025 results on Feb 07, 2025分析記事 • Nov 19Denka's (TSE:4061) Shareholders May Want To Dig Deeper Than Statutory ProfitThe stock price didn't jump after Denka Company Limited ( TSE:4061 ) posted decent earnings last week. Our analysis...Reported Earnings • Nov 09Second quarter 2025 earnings: EPS and revenues miss analyst expectationsSecond quarter 2025 results: EPS: JP¥13.02 (down from JP¥49.47 in 2Q 2024). Revenue: JP¥103.8b (flat on 2Q 2024). Net income: JP¥1.12b (down 74% from 2Q 2024). Profit margin: 1.1% (down from 4.1% in 2Q 2024). Revenue missed analyst estimates by 3.7%. Earnings per share (EPS) also missed analyst estimates by 41%. Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.分析記事 • Nov 08Fewer Investors Than Expected Jumping On Denka Company Limited (TSE:4061)There wouldn't be many who think Denka Company Limited's ( TSE:4061 ) price-to-earnings (or "P/E") ratio of 14.7x is...Major Estimate Revision • Oct 12Consensus EPS estimates fall by 22%The consensus outlook for fiscal year 2025 has been updated. 2025 consensus EPS estimate fell from JP¥133 to JP¥103. Revenue forecast reaffirmed at JP¥404.8b. Net income forecast to shrink 9.7% next year vs 11% growth forecast for Chemicals industry in Japan . Consensus price target broadly unchanged at JP¥2,612. Share price was steady at JP¥2,213 over the past week.お知らせ • Sep 27Denka Company Limited to Report Q2, 2025 Results on Nov 08, 2024Denka Company Limited announced that they will report Q2, 2025 results on Nov 08, 2024Upcoming Dividend • Sep 20Upcoming dividend of JP¥50.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 04 December 2024. Payout ratio is a comfortable 72% but the company is not cash flow positive. Trailing yield: 4.4%. Within top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (2.4%).New Risk • Sep 05New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 20% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (20% operating cash flow to total debt). Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results.Buy Or Sell Opportunity • Aug 23Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 1.0% to JP¥2,247. The fair value is estimated to be JP¥1,864, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.0% over the last 3 years. Earnings per share has declined by 41%. For the next 3 years, revenue is forecast to grow by 3.6% per annum. Earnings are also forecast to grow by 30% per annum over the same time period.分析記事 • Aug 20Calculating The Intrinsic Value Of Denka Company Limited (TSE:4061)Key Insights Using the Dividend Discount Model, Denka fair value estimate is JP¥1,864 Denka's JP¥2,222 share price...Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to JP¥1,717, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 12x in the Chemicals industry in Japan. Total loss to shareholders of 49% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at JP¥1,897 per share.Price Target Changed • Jul 08Price target decreased by 7.2% to JP¥2,465Down from JP¥2,657, the current price target is an average from 6 analysts. New target price is 14% above last closing price of JP¥2,162. Stock is down 21% over the past year. The company is forecast to post earnings per share of JP¥106 for next year compared to JP¥139 last year.Reported Earnings • Jun 25Full year 2024 earnings: EPS and revenues exceed analyst expectationsFull year 2024 results: EPS: JP¥139 (down from JP¥148 in FY 2023). Revenue: JP¥389.3b (down 4.5% from FY 2023). Net income: JP¥11.9b (down 6.4% from FY 2023). Profit margin: 3.1% (in line with FY 2023). Revenue exceeded analyst estimates by 1.6%. Earnings per share (EPS) also surpassed analyst estimates by 7.3%. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.Major Estimate Revision • Jun 19Consensus EPS estimates fall by 17%, revenue upgradedThe consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from JP¥406.4b to JP¥412.0b. EPS estimate fell from JP¥128 to JP¥106 per share. Net income forecast to shrink 24% next year vs 10% growth forecast for Chemicals industry in Japan . Consensus price target down from JP¥2,657 to JP¥2,540. Share price was steady at JP¥2,120 over the past week.お知らせ • Jun 15Denka Company Limited to Report Q1, 2025 Results on Aug 07, 2024Denka Company Limited announced that they will report Q1, 2025 results on Aug 07, 2024分析記事 • May 21Weak Statutory Earnings May Not Tell The Whole Story For Denka (TSE:4061)The subdued market reaction suggests that Denka Company Limited's ( TSE:4061 ) recent earnings didn't contain any...Reported Earnings • May 12Full year 2024 earnings: EPS and revenues exceed analyst expectationsFull year 2024 results: EPS: JP¥139 (down from JP¥148 in FY 2023). Revenue: JP¥389.3b (down 4.5% from FY 2023). Net income: JP¥11.9b (down 6.4% from FY 2023). Profit margin: 3.1% (in line with FY 2023). Revenue exceeded analyst estimates by 1.6%. Earnings per share (EPS) also surpassed analyst estimates by 7.3%. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings.お知らせ • May 12Denka Company Limited, Annual General Meeting, Jun 20, 2024Denka Company Limited, Annual General Meeting, Jun 20, 2024.お知らせ • Apr 24Denka Company Limited (TSE:4061) agreed to acquire 50% stake in Frontier Carbon Corporation from Mitsubishi Corporation (TSE:8058).Denka Company Limited (TSE:4061) agreed to acquire 50% stake in Frontier Carbon Corporation from Mitsubishi Corporation (TSE:8058) on April 24, 2024.Upcoming Dividend • Mar 21Upcoming dividend of JP¥40.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 24 June 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 4.0%. Within top quartile of Japanese dividend payers (3.2%). Higher than average of industry peers (2.1%).分析記事 • Mar 06Here's Why Denka (TSE:4061) Is Weighed Down By Its Debt LoadWarren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...お知らせ • Mar 02Denka Company Limited to Report Fiscal Year 2024 Results on May 10, 2024Denka Company Limited announced that they will report fiscal year 2024 results on May 10, 2024Reported Earnings • Feb 09Third quarter 2024 earnings: EPS and revenues miss analyst expectationsThird quarter 2024 results: JP¥34.55 loss per share (improved from JP¥63.61 loss in 3Q 2023). Revenue: JP¥101.5b (down 4.1% from 3Q 2023). Net loss: JP¥2.98b (loss narrowed 46% from 3Q 2023). Revenue missed analyst estimates by 1.1%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 4.3% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.Major Estimate Revision • Jan 25Consensus EPS estimates fall by 25%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from JP¥401.8b to JP¥392.8b. EPS estimate also fell from JP¥175 per share to JP¥132 per share. Net income forecast to grow 197% next year vs 14% growth forecast for Chemicals industry in Japan. Consensus price target down from JP¥2,900 to JP¥2,830. Share price rose 2.3% to JP¥2,573 over the past week.お知らせ • Dec 09Denka Company Limited to Report Q3, 2024 Results on Feb 07, 2024Denka Company Limited announced that they will report Q3, 2024 results on Feb 07, 2024Reported Earnings • Nov 09Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2024 results: EPS: JP¥49.47 (down from JP¥116 in 2Q 2023). Revenue: JP¥103.5b (down 4.6% from 2Q 2023). Net income: JP¥4.26b (down 57% from 2Q 2023). Profit margin: 4.1% (down from 9.2% in 2Q 2023). Revenue exceeded analyst estimates by 1.3%. Earnings per share (EPS) missed analyst estimates by 5.1%. Revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.Major Estimate Revision • Oct 07Consensus EPS estimates fall by 13%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from JP¥413.5b to JP¥404.6b. EPS estimate also fell from JP¥228 per share to JP¥199 per share. Net income forecast to grow 70% next year vs 8.0% growth forecast for Chemicals industry in Japan. Consensus price target down from JP¥3,284 to JP¥3,137. Share price was steady at JP¥2,690 over the past week.Upcoming Dividend • Sep 21Upcoming dividend of JP¥60.00 per share at 4.2% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 04 December 2023. Payout ratio is on the higher end at 80% but the company is not cash flow positive. Trailing yield: 4.2%. Within top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (2.5%).お知らせ • Sep 02Denka Company Limited to Report Q2, 2024 Results on Nov 08, 2023Denka Company Limited announced that they will report Q2, 2024 results on Nov 08, 2023Reported Earnings • Aug 08First quarter 2024 earnings released: EPS: JP¥26.62 (vs JP¥50.30 in 1Q 2023)First quarter 2024 results: EPS: JP¥26.62 (down from JP¥50.30 in 1Q 2023). Revenue: JP¥87.8b (down 6.9% from 1Q 2023). Net income: JP¥2.30b (down 47% from 1Q 2023). Profit margin: 2.6% (down from 4.6% in 1Q 2023). Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.Reported Earnings • Jun 28Full year 2023 earnings: EPS misses analyst expectationsFull year 2023 results: EPS: JP¥148 (down from JP¥302 in FY 2022). Revenue: JP¥407.6b (up 5.9% from FY 2022). Net income: JP¥12.8b (down 51% from FY 2022). Profit margin: 3.1% (down from 6.8% in FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 9.4%. Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 3.9% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.Price Target Changed • Jun 17Price target decreased by 8.0% to JP¥3,459Down from JP¥3,759, the current price target is an average from 8 analysts. New target price is 31% above last closing price of JP¥2,632. Stock is down 20% over the past year. The company is forecast to post earnings per share of JP¥256 for next year compared to JP¥148 last year.お知らせ • Jun 09Denka Company Limited to Report Q1, 2024 Results on Aug 07, 2023Denka Company Limited announced that they will report Q1, 2024 results on Aug 07, 2023お知らせ • May 13Denka Company Limited, Annual General Meeting, Jun 22, 2023Denka Company Limited, Annual General Meeting, Jun 22, 2023.Reported Earnings • May 13Full year 2023 earnings: EPS misses analyst expectationsFull year 2023 results: EPS: JP¥148 (down from JP¥302 in FY 2022). Revenue: JP¥407.6b (up 5.9% from FY 2022). Net income: JP¥12.8b (down 51% from FY 2022). Profit margin: 3.1% (down from 6.8% in FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 9.4%. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.Upcoming Dividend • Mar 23Upcoming dividend of JP¥30.00 per share at 5.3% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 23 June 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 5.3%. Within top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.8%).Major Estimate Revision • Mar 16Consensus EPS estimates fall by 15%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from JP¥424.0b to JP¥416.3b. EPS estimate also fell from JP¥204 per share to JP¥173 per share. Net income forecast to grow 101% next year vs 1.4% growth forecast for Chemicals industry in Japan. Consensus price target down from JP¥4,019 to JP¥3,906. Share price fell 5.8% to JP¥2,710 over the past week.Buying Opportunity • Mar 14Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 15%. The fair value is estimated to be JP¥3,410, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 2.8% over the last 3 years. Earnings per share has declined by 3.4%. For the next 3 years, revenue is forecast to grow by 2.8% per annum. Earnings is also forecast to grow by 23% per annum over the same time period.収支内訳Denka の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史TSE:4061 収益、費用、利益 ( )JPY Millions日付収益収益G+A経費研究開発費31 Mar 26384,24715,69568,030031 Dec 25389,427-9,34268,565030 Sep 25397,896-11,77057,99212,44530 Jun 25399,074-12,03570,310031 Mar 25400,251-12,30057,73712,44531 Dec 24398,01810,94258,86912,68030 Sep 24396,9488,76057,18812,68030 Jun 24396,66111,90256,92312,68031 Mar 24389,26311,94756,44412,68031 Dec 23391,6697,50854,79812,68030 Sep 23396,0005,00055,56712,68030 Jun 23401,01910,72656,15912,68031 Mar 23407,55912,76857,33712,68031 Dec 22409,60511,94357,72511,94730 Sep 22396,63422,29457,27311,94730 Jun 22392,49124,19356,62511,94731 Mar 22384,84926,01255,10411,94731 Dec 21376,38326,80654,76312,50130 Sep 21385,23230,82254,41412,50130 Jun 21364,88524,75153,67312,50131 Mar 21354,39122,78552,96312,50131 Dec 20354,13324,89353,15912,61930 Sep 20349,15221,85953,65512,61930 Jun 20366,15221,87554,58812,61931 Mar 20380,80322,70355,13112,61931 Dec 19391,49923,32455,30211,98630 Sep 19406,73324,50855,60211,98630 Jun 19410,04323,83655,91711,98631 Mar 19413,12825,04656,07411,98631 Dec 18412,78322,51057,16911,47730 Sep 18406,13422,15056,15211,47730 Jun 18399,01023,22055,75111,47731 Mar 18395,62923,03554,91711,47731 Dec 17389,03723,53854,65811,10230 Sep 17378,68424,30653,93911,10230 Jun 17371,25121,95652,76711,10231 Mar 17362,64718,14552,43711,10231 Dec 16359,13417,16253,2579,65630 Sep 16359,03215,70152,5009,65630 Jun 16364,90817,33852,1869,65631 Mar 16369,85319,47251,4989,65631 Dec 15372,60121,03250,9758,79630 Sep 15379,73521,38350,4338,79630 Jun 15384,05121,36249,0708,796質の高い収益: 4061は 高品質の収益 を持っています。利益率の向上: 4061過去に利益を上げました。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 4061の収益は過去 5 年間で年間44.4%減少しました。成長の加速: 4061は昨年収益を上げたため、収益成長率を 5 年間の平均と比較することは困難です。収益対業界: 4061昨年収益を上げたため、昨年の収益成長をChemicals業界 ( 11% ) と比較することは困難です。株主資本利益率高いROE: 4061の 自己資本利益率 ( 3.3% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/10 05:18終値2026/06/10 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Denka Company Limited 5 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。14 アナリスト機関Takashi EnomotoBofA Global ResearchAtsushi IkedaCitigroup IncHidemitsu UmebayashiDaiwa Securities Co. Ltd.11 その他のアナリストを表示
分析記事 • May 21We Like Denka's (TSE:4061) Earnings For More Than Just Statutory ProfitThe market seemed underwhelmed by the solid earnings posted by Denka Company Limited ( TSE:4061 ) recently. Our...
Reported Earnings • May 14Full year 2026 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2026 results: EPS: JP¥182 (up from JP¥143 loss in FY 2025). Revenue: JP¥384.2b (down 4.0% from FY 2025). Net income: JP¥15.7b (up JP¥28.0b from FY 2025). Profit margin: 4.1% (up from net loss in FY 2025). The move to profitability was driven by lower expenses. Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) exceeded analyst estimates by 6.5%. Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.
お知らせ • Apr 22+ 3 more updatesDenka Company Limited to Report Q2, 2027 Results on Nov 09, 2026Denka Company Limited announced that they will report Q2, 2027 results on Nov 09, 2026
Reported Earnings • Feb 07Third quarter 2026 earnings: EPS and revenues miss analyst expectationsThird quarter 2026 results: EPS: JP¥18.94 (up from JP¥9.23 loss in 3Q 2025). Revenue: JP¥94.1b (down 8.3% from 3Q 2025). Net income: JP¥1.63b (up JP¥2.43b from 3Q 2025). Profit margin: 1.7% (up from net loss in 3Q 2025). Revenue missed analyst estimates by 8.1%. Earnings per share (EPS) also missed analyst estimates by 72%. Revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance.
お知らせ • Dec 24Denka Company Limited to Report Q3, 2026 Results on Feb 06, 2026Denka Company Limited announced that they will report Q3, 2026 results on Feb 06, 2026
Reported Earnings • Nov 11Second quarter 2026 earnings: EPS misses analyst expectationsSecond quarter 2026 results: JP¥12.75 loss per share (down from JP¥13.02 profit in 2Q 2025). Revenue: JP¥102.6b (down 1.2% from 2Q 2025). Net loss: JP¥1.10b (down 198% from profit in 2Q 2025). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates. Revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance.
Valuation Update With 7 Day Price Move • May 29Investor sentiment improves as stock rises 16%After last week's 16% share price gain to JP¥4,480, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 15x in the Chemicals industry in Japan. Total returns to shareholders of 97% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at JP¥6,464 per share.
分析記事 • May 21We Like Denka's (TSE:4061) Earnings For More Than Just Statutory ProfitThe market seemed underwhelmed by the solid earnings posted by Denka Company Limited ( TSE:4061 ) recently. Our...
Reported Earnings • May 14Full year 2026 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2026 results: EPS: JP¥182 (up from JP¥143 loss in FY 2025). Revenue: JP¥384.2b (down 4.0% from FY 2025). Net income: JP¥15.7b (up JP¥28.0b from FY 2025). Profit margin: 4.1% (up from net loss in FY 2025). The move to profitability was driven by lower expenses. Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) exceeded analyst estimates by 6.5%. Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings.
お知らせ • May 13Denka Company Limited, Annual General Meeting, Jun 19, 2026Denka Company Limited, Annual General Meeting, Jun 19, 2026.
お知らせ • Apr 22+ 3 more updatesDenka Company Limited to Report Q2, 2027 Results on Nov 09, 2026Denka Company Limited announced that they will report Q2, 2027 results on Nov 09, 2026
お知らせ • Mar 26Denka Company Limited (TSE:4061) completed the acquisition of 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders.Denka Company Limited (TSE:4061) proposed to acquire 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders for ¥7.9 billion on February 6, 2026. A cash consideration of ¥7.89 billion valued at ¥2285 per share will be paid by Denka Company Limited. As part of consideration, ¥7.89 billion is paid towards common equity of KAINOS Laboratories, Inc. Denka Company Limited intends to launch a Squeeze-Out Procedures, if it acquires the minimum tender shares (1,990,000 shares) and fails to acquire all of the KAINOS Laboratories, Inc's Shares (excluding the Shares Agreed Not to Be Tendered and treasury shares). The transaction is subject to minimum tender. The expected completion of the transaction is March 25, 2026. Sumitomo Mitsui Banking Corporation acted as financial advisor for Denka Company Limited. AGS Consulting Co., Ltd. acted as financial advisor for KAINOS Laboratories, Inc. Nagashima Ohno & Tsunematsu acted as legal advisor for KAINOS Laboratories, Inc. TMI Associates acted as legal advisor for KAINOS Laboratories, Inc. Mizuho Securities Co., Ltd. acted as financial advisor for KAINOS Laboratories, Inc. Denka Company Limited (TSE:4061) completed the acquisition of 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders on March 25, 2026. Upon closing of the offer period, 3,223,919 shares were tendered. Since it is more than the minimum number of shares to be purchased (1,990,000 shares), Denka Company Limited will purchase all of the Tendered Share Certificates and intends to implement a series of procedures for the purpose of making the Tender Offeror the sole shareholder of KAINOS Laboratories, Inc. As of today, the KAINOS Laboratories, Inc's Shares are listed on the Standard Market of the Tokyo Stock Exchange. If the procedures are implemented, the KAINOS Laboratories, Inc's Shares will be delisted pursuant to the prescribed procedures, in accordance with the criteria for delisting of Tokyo Stock Exchange. KAINOS Laboratories, Inc's Shares, after being delisted, will no longer be traded on the Standard Market of the Tokyo Stock Exchange.
Price Target Changed • Mar 24Price target increased by 7.5% to JP¥3,866Up from JP¥3,597, the current price target is an average from 7 analysts. New target price is 17% above last closing price of JP¥3,294. Stock is up 47% over the past year. The company is forecast to post earnings per share of JP¥171 next year compared to a net loss per share of JP¥143 last year.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥50.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 23 June 2026. The company is not currently making a profit and is not cash flow positive. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.3%).
New Risk • Mar 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (13% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risk Share price has been volatile over the past 3 months (6.2% average weekly change).
お知らせ • Mar 10Denka Company Limited (TSE:4061) enter into a share transfer agreement to acquire an additional 15% stake in Toyo Styrene Co. Ltd from Daicel Corporation (TSE:4202).Denka Company Limited (TSE:4061) enter into a share transfer agreement to acquire an additional 15% stake in Toyo Styrene Co. Ltd from Daicel Corporation (TSE:4202) on March 9, 2026. Upon completion, Denka Company Limited will own 65% stake in Toyo Styrene Co. Ltd. As a result of this transaction, Toyo Styrene is expected to become a consolidated subsidiary of the Company that qualifies as a specified subsidiary. Daicel will cease to be a co-investor in Toyo Styrene, and Toyo Styrene’s Hirohata Plant will be shut down. For a certain period, however, Toyo Styrene will continue to outsource production to Daicel and maintain product sales. For the period ending March 31, 2025, Toyo Styrene Co. Ltd reported total revenue of ¥48.39 billion, EBIT of ¥1.22 billion and net income of ¥788 million. As of March 31, 2025, Toyo Styrene Co. Ltd reported total assets of ¥27.69 billion and total common equity of ¥11.73 billion. The completion of this share transfer is subject to the completion of the necessary approvals, permissions, or clearances from the relevant authorities in accordance with the Anti-Monopoly Act and other applicable laws and regulations. The expected completion of the transaction is March 31, 2026.
Price Target Changed • Mar 02Price target increased by 8.2% to JP¥3,469Up from JP¥3,206, the current price target is an average from 7 analysts. New target price is approximately in line with last closing price of JP¥3,496. Stock is up 69% over the past year. The company is forecast to post earnings per share of JP¥179 next year compared to a net loss per share of JP¥143 last year.
分析記事 • Feb 09Denka (TSE:4061) Has Announced A Dividend Of ¥50.00The board of Denka Company Limited ( TSE:4061 ) has announced that it will pay a dividend on the 23rd of June, with...
お知らせ • Feb 09Denka Company Limited (TSE:4061) proposed to acquire 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders for ¥7.9 billion.Denka Company Limited (TSE:4061) proposed to acquire 77.65% stake in KAINOS Laboratories, Inc. (TSE:4556) from a group of shareholders for ¥7.9 billion on February 6, 2026. A cash consideration of ¥7.89 billion valued at ¥2285 per share will be paid by Denka Company Limited. As part of consideration, ¥7.89 billion is paid towards common equity of KAINOS Laboratories, Inc. The transaction is subject to minimum tender. The expected completion of the transaction is March 25, 2026. Sumitomo Mitsui Banking Corporation acted as financial advisor for Denka Company Limited. AGS Consulting Co., Ltd. acted as financial advisor for KAINOS Laboratories, Inc. Nagashima Ohno & Tsunematsu acted as legal advisor for KAINOS Laboratories, Inc. TMI Associates acted as legal advisor for KAINOS Laboratories, Inc. Mizuho Securities Co., Ltd. acted as financial advisor for KAINOS Laboratories, Inc.
Reported Earnings • Feb 07Third quarter 2026 earnings: EPS and revenues miss analyst expectationsThird quarter 2026 results: EPS: JP¥18.94 (up from JP¥9.23 loss in 3Q 2025). Revenue: JP¥94.1b (down 8.3% from 3Q 2025). Net income: JP¥1.63b (up JP¥2.43b from 3Q 2025). Profit margin: 1.7% (up from net loss in 3Q 2025). Revenue missed analyst estimates by 8.1%. Earnings per share (EPS) also missed analyst estimates by 72%. Revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance.
分析記事 • Feb 05Denka Company Limited's (TSE:4061) Price Is Out Of Tune With RevenuesIt's not a stretch to say that Denka Company Limited's ( TSE:4061 ) price-to-sales (or "P/S") ratio of 0.7x seems quite...
分析記事 • Jan 14Denka (TSE:4061) Has A Somewhat Strained Balance SheetThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Price Target Changed • Jan 06Price target increased by 10% to JP¥3,167Up from JP¥2,867, the current price target is an average from 7 analysts. New target price is 10% above last closing price of JP¥2,876. Stock is up 28% over the past year. The company is forecast to post earnings per share of JP¥178 next year compared to a net loss per share of JP¥143 last year.
分析記事 • Dec 24Denka (TSE:4061) Will Pay A Dividend Of ¥50.00The board of Denka Company Limited ( TSE:4061 ) has announced that it will pay a dividend of ¥50.00 per share on the...
お知らせ • Dec 24Denka Company Limited to Report Q3, 2026 Results on Feb 06, 2026Denka Company Limited announced that they will report Q3, 2026 results on Feb 06, 2026
分析記事 • Dec 03Denka (TSE:4061) Will Pay A Dividend Of ¥50.00The board of Denka Company Limited ( TSE:4061 ) has announced that it will pay a dividend of ¥50.00 per share on the...
Declared Dividend • Dec 03First half dividend of JP¥50.00 announcedDividend of JP¥50.00 is the same as last year. Ex-date: 30th March 2026 Payment date: 23rd June 2026 Dividend yield will be 3.8%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 7.2% per year over the past 10 years. However, payments have been volatile during that time.
Price Target Changed • Nov 26Price target increased by 13% to JP¥2,696Up from JP¥2,380, the current price target is an average from 7 analysts. New target price is 6.0% above last closing price of JP¥2,543. Stock is up 19% over the past year. The company is forecast to post earnings per share of JP¥181 next year compared to a net loss per share of JP¥143 last year.
Price Target Changed • Nov 14Price target increased by 8.5% to JP¥2,338Up from JP¥2,155, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of JP¥2,448. Stock is up 20% over the past year. The company is forecast to post earnings per share of JP¥172 next year compared to a net loss per share of JP¥143 last year.
Reported Earnings • Nov 11Second quarter 2026 earnings: EPS misses analyst expectationsSecond quarter 2026 results: JP¥12.75 loss per share (down from JP¥13.02 profit in 2Q 2025). Revenue: JP¥102.6b (down 1.2% from 2Q 2025). Net loss: JP¥1.10b (down 198% from profit in 2Q 2025). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates. Revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance.
分析記事 • Oct 14Denka Company Limited (TSE:4061) Not Flying Under The RadarIt's not a stretch to say that Denka Company Limited's ( TSE:4061 ) price-to-sales (or "P/S") ratio of 0.5x right now...
Upcoming Dividend • Sep 22Upcoming dividend of JP¥50.00 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 03 December 2025. The company is not currently making a profit and is not cash flow positive. Trailing yield: 4.2%. Within top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.6%).
分析記事 • Sep 22Denka (TSE:4061) Is Due To Pay A Dividend Of ¥50.00The board of Denka Company Limited ( TSE:4061 ) has announced that it will pay a dividend of ¥50.00 per share on the...
お知らせ • Sep 22Denka Company Limited(TSE:4061) dropped from FTSE All-World Index (USD)Denka Company Limited(TSE:4061) dropped from FTSE All-World Index (USD)
分析記事 • Sep 03Denka (TSE:4061) Will Pay A Dividend Of ¥50.00The board of Denka Company Limited ( TSE:4061 ) has announced that it will pay a dividend on the 3rd of December, with...
お知らせ • Sep 03Denka Company Limited to Report Q2, 2026 Results on Nov 10, 2025Denka Company Limited announced that they will report Q2, 2026 results on Nov 10, 2025
Reported Earnings • Aug 08First quarter 2026 earnings: EPS exceeds analyst expectations while revenues lag behindFirst quarter 2026 results: EPS: JP¥58.03 (up from JP¥26.11 in 1Q 2025). Revenue: JP¥94.1b (down 1.2% from 1Q 2025). Net income: JP¥5.00b (up 122% from 1Q 2025). Profit margin: 5.3% (up from 2.4% in 1Q 2025). Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) exceeded analyst estimates significantly. Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 54 percentage points per year, which is a significant difference in performance.
Board Change • Jul 25Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Outside Director Rumiko Nakata was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
分析記事 • Jul 24Denka (TSE:4061) Has Affirmed Its Dividend Of ¥50.00Denka Company Limited ( TSE:4061 ) will pay a dividend of ¥50.00 on the 3rd of December. The dividend yield will be...
分析記事 • Jul 10Denka (TSE:4061) Has Announced A Dividend Of ¥50.00Denka Company Limited ( TSE:4061 ) will pay a dividend of ¥50.00 on the 3rd of December. This makes the dividend yield...
Declared Dividend • Jul 09Final dividend of JP¥50.00 announcedDividend of JP¥50.00 is the same as last year. Ex-date: 29th September 2025 Payment date: 3rd December 2025 Dividend yield will be 4.8%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is covered by earnings (71% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 7.2% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 373% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Jul 02Denka Company Limited to Report Q1, 2026 Results on Aug 07, 2025Denka Company Limited announced that they will report Q1, 2026 results on Aug 07, 2025
Reported Earnings • Jun 24Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: JP¥143 loss per share (down from JP¥139 profit in FY 2024). Revenue: JP¥400.3b (up 2.8% from FY 2024). Net loss: JP¥12.3b (down 203% from profit in FY 2024). Revenue missed analyst estimates by 2.0%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 1.7% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.
分析記事 • Jun 16Is Denka (TSE:4061) A Risky Investment?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
New Risk • May 15New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. The company is paying a dividend despite being loss-making. The company is paying a dividend despite having no free cash flows. Dividend yield: 5.0% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (8.6% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows.
Reported Earnings • May 14Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: JP¥143 loss per share (down from JP¥139 profit in FY 2024). Revenue: JP¥400.3b (up 2.8% from FY 2024). Net loss: JP¥12.3b (down 203% from profit in FY 2024). Revenue missed analyst estimates by 2.0%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 2.1% p.a. on average during the next 2 years, compared to a 4.6% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings.
分析記事 • May 13The Returns On Capital At Denka (TSE:4061) Don't Inspire ConfidenceThere are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...
お知らせ • May 13+ 3 more updatesDenka Company Limited, Annual General Meeting, Jun 20, 2025Denka Company Limited, Annual General Meeting, Jun 20, 2025.
Major Estimate Revision • Apr 29Consensus EPS estimates fall by 34%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from JP¥34.22 to JP¥22.53 per share. Revenue forecast steady at JP¥408.4b. Net income forecast to grow 6.5% next year vs 7.2% growth forecast for Chemicals industry in Japan. Consensus price target broadly unchanged at JP¥2,463. Share price rose 3.1% to JP¥1,955 over the past week.
Valuation Update With 7 Day Price Move • Apr 07Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to JP¥1,784, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 10x in the Chemicals industry in Japan. Total loss to shareholders of 39% over the past three years.
Upcoming Dividend • Mar 21Upcoming dividend of JP¥50.00 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 23 June 2025. Payout ratio is a comfortable 71% but the company is not cash flow positive. Trailing yield: 4.0%. Within top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (2.6%).
Major Estimate Revision • Mar 15Consensus EPS estimates increase by 29%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from JP¥40.53 to JP¥52.30. Revenue forecast steady at JP¥407.9b. Net income forecast to grow 13% next year vs 8.3% growth forecast for Chemicals industry in Japan. Consensus price target broadly unchanged at JP¥2,491. Share price rose 2.4% to JP¥2,200 over the past week.
Major Estimate Revision • Mar 13Consensus EPS estimates fall by 27%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from JP¥40.53 to JP¥29.69 per share. Revenue forecast steady at JP¥409.3b. Net income forecast to grow 11% next year vs 8.3% growth forecast for Chemicals industry in Japan. Consensus price target broadly unchanged at JP¥2,491. Share price rose 4.4% to JP¥2,215 over the past week.
お知らせ • Mar 12Oriental Shiraishi Corporation (TSE:1786) signed a share transfer agreement to acquire 51% stake in Denka Renotec Co., Ltd. from Denka Company Limited (TSE:4061).Oriental Shiraishi Corporation (TSE:1786) signed a share transfer agreement to acquire 51% stake in Denka Renotec Co., Ltd. from Denka Company Limited (TSE:4061) on March 12, 2025. Even after the transfer of shares, Denka Renotec will remain an equity-method affiliate of Denka Company Limited.
Reported Earnings • Feb 08Third quarter 2025 earnings: EPS and revenues miss analyst expectationsThird quarter 2025 results: JP¥9.23 loss per share (improved from JP¥34.55 loss in 3Q 2024). Revenue: JP¥102.5b (up 1.1% from 3Q 2024). Net loss: JP¥795.0m (loss narrowed 73% from 3Q 2024). Revenue missed analyst estimates by 3.9%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 1.7% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.
Major Estimate Revision • Jan 29Consensus EPS estimates fall by 13%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from JP¥42.94 to JP¥37.52 per share. Revenue forecast steady at JP¥409.6b. Net income forecast to grow 4.8% next year vs 13% growth forecast for Chemicals industry in Japan. Consensus price target broadly unchanged at JP¥2,477. Share price rose 5.7% to JP¥2,244 over the past week.
分析記事 • Jan 27Denka (TSE:4061) Use Of Debt Could Be Considered RiskyThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Major Estimate Revision • Jan 17Consensus EPS estimates fall from profit to JP¥1.16 lossThe consensus outlook for fiscal year 2025 has been updated. Expected to report loss instead of -JP¥1.16 instead of JP¥18.90 per share profit previously forecast. Revenue forecast unchanged at JP¥409.3b Chemicals industry in Japan expected to see average net income growth of 13% next year. Consensus price target broadly unchanged at JP¥2,493. Share price fell 3.2% to JP¥2,104 over the past week.
Major Estimate Revision • Jan 11Consensus EPS estimates fall by 50%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from JP¥18.90 to JP¥9.48 per share. Revenue forecast steady at JP¥409.3b. Net income forecast to shrink 11% next year vs 13% growth forecast for Chemicals industry in Japan . Consensus price target of JP¥2,507 unchanged from last update. Share price fell 2.6% to JP¥2,173 over the past week.
分析記事 • Dec 30Denka (TSE:4061) Could Be Struggling To Allocate CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...
Major Estimate Revision • Dec 27Consensus EPS estimates increase from loss to JP¥18.90 profitThe consensus outlook for fiscal year 2025 has been updated. 2025 forecast for profit of -JP¥6.63 instead of a loss of JP¥18.90 per share previously. Revenue forecast unchanged at JP¥409.1b. Chemicals industry in Japan expected to see average net income growth of 13% next year. Consensus price target broadly unchanged at JP¥2,507. Share price rose 5.4% to JP¥2,218 over the past week.
Major Estimate Revision • Dec 13Consensus EPS estimates fall from profit to JP¥6.63 lossThe consensus outlook for fiscal year 2025 has been updated. Expected to report loss instead of -JP¥6.63 instead of JP¥21.46 per share profit previously forecast. Revenue forecast unchanged at JP¥409.1b Chemicals industry in Japan expected to see average net income growth of 13% next year. Consensus price target broadly unchanged at JP¥2,534. Share price was steady at JP¥2,167 over the past week.
お知らせ • Dec 03Denka Company Limited to Report Q3, 2025 Results on Feb 07, 2025Denka Company Limited announced that they will report Q3, 2025 results on Feb 07, 2025
分析記事 • Nov 19Denka's (TSE:4061) Shareholders May Want To Dig Deeper Than Statutory ProfitThe stock price didn't jump after Denka Company Limited ( TSE:4061 ) posted decent earnings last week. Our analysis...
Reported Earnings • Nov 09Second quarter 2025 earnings: EPS and revenues miss analyst expectationsSecond quarter 2025 results: EPS: JP¥13.02 (down from JP¥49.47 in 2Q 2024). Revenue: JP¥103.8b (flat on 2Q 2024). Net income: JP¥1.12b (down 74% from 2Q 2024). Profit margin: 1.1% (down from 4.1% in 2Q 2024). Revenue missed analyst estimates by 3.7%. Earnings per share (EPS) also missed analyst estimates by 41%. Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.
分析記事 • Nov 08Fewer Investors Than Expected Jumping On Denka Company Limited (TSE:4061)There wouldn't be many who think Denka Company Limited's ( TSE:4061 ) price-to-earnings (or "P/E") ratio of 14.7x is...
Major Estimate Revision • Oct 12Consensus EPS estimates fall by 22%The consensus outlook for fiscal year 2025 has been updated. 2025 consensus EPS estimate fell from JP¥133 to JP¥103. Revenue forecast reaffirmed at JP¥404.8b. Net income forecast to shrink 9.7% next year vs 11% growth forecast for Chemicals industry in Japan . Consensus price target broadly unchanged at JP¥2,612. Share price was steady at JP¥2,213 over the past week.
お知らせ • Sep 27Denka Company Limited to Report Q2, 2025 Results on Nov 08, 2024Denka Company Limited announced that they will report Q2, 2025 results on Nov 08, 2024
Upcoming Dividend • Sep 20Upcoming dividend of JP¥50.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 04 December 2024. Payout ratio is a comfortable 72% but the company is not cash flow positive. Trailing yield: 4.4%. Within top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (2.4%).
New Risk • Sep 05New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 20% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (20% operating cash flow to total debt). Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results.
Buy Or Sell Opportunity • Aug 23Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 1.0% to JP¥2,247. The fair value is estimated to be JP¥1,864, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.0% over the last 3 years. Earnings per share has declined by 41%. For the next 3 years, revenue is forecast to grow by 3.6% per annum. Earnings are also forecast to grow by 30% per annum over the same time period.
分析記事 • Aug 20Calculating The Intrinsic Value Of Denka Company Limited (TSE:4061)Key Insights Using the Dividend Discount Model, Denka fair value estimate is JP¥1,864 Denka's JP¥2,222 share price...
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to JP¥1,717, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 12x in the Chemicals industry in Japan. Total loss to shareholders of 49% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at JP¥1,897 per share.
Price Target Changed • Jul 08Price target decreased by 7.2% to JP¥2,465Down from JP¥2,657, the current price target is an average from 6 analysts. New target price is 14% above last closing price of JP¥2,162. Stock is down 21% over the past year. The company is forecast to post earnings per share of JP¥106 for next year compared to JP¥139 last year.
Reported Earnings • Jun 25Full year 2024 earnings: EPS and revenues exceed analyst expectationsFull year 2024 results: EPS: JP¥139 (down from JP¥148 in FY 2023). Revenue: JP¥389.3b (down 4.5% from FY 2023). Net income: JP¥11.9b (down 6.4% from FY 2023). Profit margin: 3.1% (in line with FY 2023). Revenue exceeded analyst estimates by 1.6%. Earnings per share (EPS) also surpassed analyst estimates by 7.3%. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.
Major Estimate Revision • Jun 19Consensus EPS estimates fall by 17%, revenue upgradedThe consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from JP¥406.4b to JP¥412.0b. EPS estimate fell from JP¥128 to JP¥106 per share. Net income forecast to shrink 24% next year vs 10% growth forecast for Chemicals industry in Japan . Consensus price target down from JP¥2,657 to JP¥2,540. Share price was steady at JP¥2,120 over the past week.
お知らせ • Jun 15Denka Company Limited to Report Q1, 2025 Results on Aug 07, 2024Denka Company Limited announced that they will report Q1, 2025 results on Aug 07, 2024
分析記事 • May 21Weak Statutory Earnings May Not Tell The Whole Story For Denka (TSE:4061)The subdued market reaction suggests that Denka Company Limited's ( TSE:4061 ) recent earnings didn't contain any...
Reported Earnings • May 12Full year 2024 earnings: EPS and revenues exceed analyst expectationsFull year 2024 results: EPS: JP¥139 (down from JP¥148 in FY 2023). Revenue: JP¥389.3b (down 4.5% from FY 2023). Net income: JP¥11.9b (down 6.4% from FY 2023). Profit margin: 3.1% (in line with FY 2023). Revenue exceeded analyst estimates by 1.6%. Earnings per share (EPS) also surpassed analyst estimates by 7.3%. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings.
お知らせ • May 12Denka Company Limited, Annual General Meeting, Jun 20, 2024Denka Company Limited, Annual General Meeting, Jun 20, 2024.
お知らせ • Apr 24Denka Company Limited (TSE:4061) agreed to acquire 50% stake in Frontier Carbon Corporation from Mitsubishi Corporation (TSE:8058).Denka Company Limited (TSE:4061) agreed to acquire 50% stake in Frontier Carbon Corporation from Mitsubishi Corporation (TSE:8058) on April 24, 2024.
Upcoming Dividend • Mar 21Upcoming dividend of JP¥40.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 24 June 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 4.0%. Within top quartile of Japanese dividend payers (3.2%). Higher than average of industry peers (2.1%).
分析記事 • Mar 06Here's Why Denka (TSE:4061) Is Weighed Down By Its Debt LoadWarren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
お知らせ • Mar 02Denka Company Limited to Report Fiscal Year 2024 Results on May 10, 2024Denka Company Limited announced that they will report fiscal year 2024 results on May 10, 2024
Reported Earnings • Feb 09Third quarter 2024 earnings: EPS and revenues miss analyst expectationsThird quarter 2024 results: JP¥34.55 loss per share (improved from JP¥63.61 loss in 3Q 2023). Revenue: JP¥101.5b (down 4.1% from 3Q 2023). Net loss: JP¥2.98b (loss narrowed 46% from 3Q 2023). Revenue missed analyst estimates by 1.1%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 4.3% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings.
Major Estimate Revision • Jan 25Consensus EPS estimates fall by 25%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from JP¥401.8b to JP¥392.8b. EPS estimate also fell from JP¥175 per share to JP¥132 per share. Net income forecast to grow 197% next year vs 14% growth forecast for Chemicals industry in Japan. Consensus price target down from JP¥2,900 to JP¥2,830. Share price rose 2.3% to JP¥2,573 over the past week.
お知らせ • Dec 09Denka Company Limited to Report Q3, 2024 Results on Feb 07, 2024Denka Company Limited announced that they will report Q3, 2024 results on Feb 07, 2024
Reported Earnings • Nov 09Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2024 results: EPS: JP¥49.47 (down from JP¥116 in 2Q 2023). Revenue: JP¥103.5b (down 4.6% from 2Q 2023). Net income: JP¥4.26b (down 57% from 2Q 2023). Profit margin: 4.1% (down from 9.2% in 2Q 2023). Revenue exceeded analyst estimates by 1.3%. Earnings per share (EPS) missed analyst estimates by 5.1%. Revenue is forecast to grow 3.4% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.
Major Estimate Revision • Oct 07Consensus EPS estimates fall by 13%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from JP¥413.5b to JP¥404.6b. EPS estimate also fell from JP¥228 per share to JP¥199 per share. Net income forecast to grow 70% next year vs 8.0% growth forecast for Chemicals industry in Japan. Consensus price target down from JP¥3,284 to JP¥3,137. Share price was steady at JP¥2,690 over the past week.
Upcoming Dividend • Sep 21Upcoming dividend of JP¥60.00 per share at 4.2% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 04 December 2023. Payout ratio is on the higher end at 80% but the company is not cash flow positive. Trailing yield: 4.2%. Within top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (2.5%).
お知らせ • Sep 02Denka Company Limited to Report Q2, 2024 Results on Nov 08, 2023Denka Company Limited announced that they will report Q2, 2024 results on Nov 08, 2023
Reported Earnings • Aug 08First quarter 2024 earnings released: EPS: JP¥26.62 (vs JP¥50.30 in 1Q 2023)First quarter 2024 results: EPS: JP¥26.62 (down from JP¥50.30 in 1Q 2023). Revenue: JP¥87.8b (down 6.9% from 1Q 2023). Net income: JP¥2.30b (down 47% from 1Q 2023). Profit margin: 2.6% (down from 4.6% in 1Q 2023). Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
Reported Earnings • Jun 28Full year 2023 earnings: EPS misses analyst expectationsFull year 2023 results: EPS: JP¥148 (down from JP¥302 in FY 2022). Revenue: JP¥407.6b (up 5.9% from FY 2022). Net income: JP¥12.8b (down 51% from FY 2022). Profit margin: 3.1% (down from 6.8% in FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 9.4%. Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 3.9% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
Price Target Changed • Jun 17Price target decreased by 8.0% to JP¥3,459Down from JP¥3,759, the current price target is an average from 8 analysts. New target price is 31% above last closing price of JP¥2,632. Stock is down 20% over the past year. The company is forecast to post earnings per share of JP¥256 for next year compared to JP¥148 last year.
お知らせ • Jun 09Denka Company Limited to Report Q1, 2024 Results on Aug 07, 2023Denka Company Limited announced that they will report Q1, 2024 results on Aug 07, 2023
お知らせ • May 13Denka Company Limited, Annual General Meeting, Jun 22, 2023Denka Company Limited, Annual General Meeting, Jun 22, 2023.
Reported Earnings • May 13Full year 2023 earnings: EPS misses analyst expectationsFull year 2023 results: EPS: JP¥148 (down from JP¥302 in FY 2022). Revenue: JP¥407.6b (up 5.9% from FY 2022). Net income: JP¥12.8b (down 51% from FY 2022). Profit margin: 3.1% (down from 6.8% in FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 9.4%. Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥30.00 per share at 5.3% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 23 June 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 5.3%. Within top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.8%).
Major Estimate Revision • Mar 16Consensus EPS estimates fall by 15%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from JP¥424.0b to JP¥416.3b. EPS estimate also fell from JP¥204 per share to JP¥173 per share. Net income forecast to grow 101% next year vs 1.4% growth forecast for Chemicals industry in Japan. Consensus price target down from JP¥4,019 to JP¥3,906. Share price fell 5.8% to JP¥2,710 over the past week.
Buying Opportunity • Mar 14Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 15%. The fair value is estimated to be JP¥3,410, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 2.8% over the last 3 years. Earnings per share has declined by 3.4%. For the next 3 years, revenue is forecast to grow by 2.8% per annum. Earnings is also forecast to grow by 23% per annum over the same time period.